ARTICLE | Product Development
Antigen picking strategies
May 29, 2006 7:00 AM UTC
Cautious Optimism
While developers of cancer vaccines now have a much clearer picture of the setting for prosecuting the immune response, what remains unresolved is "who" should choose the target antigens - the drug or the patient's immune system...